Regulatory factor X5 promotes hepatocellular carcinoma progression by transactivating tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta and suppressing apoptosis
Dongbo Chen(Diponegoro University), Hongsong Chen(Inner Mongolia University for Nationalities), Kangjian Deng(Guilin Medical University), Qixiang Shao(Jiangsu University), Yangjing Zhao(Jiangsu University), Weijia Liao(Guilin Medical University), Xingwang Xie(Peking University), Xueyan Wang(Peking University), Cong Xu(Tongji Hospital), Pu Chen(Beijing University of Chinese Medicine), Xu Wu, Ran Fei(Peking University), Lai Wei(Nanjing University of Finance and Economics)
Cited by 28
Related Papers
New progress in the pharmacology of protocatechuic acid: A compound ingested in daily foods and herbs frequently and heavily
|Pharmacological Research|2020|301
Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma
|Journal of Experimental & Clinical Cancer Research|2015|271
Mouse Embryonic Head as a Site for Hematopoietic Stem Cell Development
|Cell stem cell|2012|192
Functional Roles of Chemokine Receptor CCR2 and Its Ligands in Liver Disease
|Frontiers in Immunology|2022|122
The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease
|Journal of Hepatology|2021|118